Co-Authors
This is a "connection" page, showing publications co-authored by Woo Kim and Joong Eom.
Connection Strength
0.281
-
Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial. J Clin Med. 2021 Aug 12; 10(16).
Score: 0.240
-
Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities. Infect Chemother. 2015 Dec; 47(4):278-302.
Score: 0.041